Abstract. Multiple studies have reported the prognostic association of certain inflammatory factors with various types of cancer. The present study assessed the prognostic value of the C-reactive protein (CRP)/albumin (Alb) ratio and the neutrophil/lymphocyte ratio (NLR), separately and in combination, in gastric cancer (GC). A total of 337 cases pathologically diagnosed with gastric adenocarcinoma were retrospectively evaluated. The clinicopathological and prognostic relevance of the CRP/Alb ratio and NLR and their combination were analyzed. The optimal cut-off values of the CRP/Alb ratio and NLR were 0.38 and 3.14, respectively. High CRP/Alb ratio (≥0.38) and NLR (≥3.14) values were associated with increased tumor invasion, more distant metastasis and a more advanced tumor-node-metastasis stage (all P<0.05). In addition, a high NLR value was also associated with increased tumor size (P= 0.02). The CRP/Alb ratio (≥0.38/<0.38) and NLR (≥3.14/<3.14) were independent prognostic factors for overall survival time (OS) in GC by multivariate analysis (P= 0.005 and P= 0.001). Using the CRP/Alb ratio and NLR classification, patients were stratified into three subgroups with different OS time (P<0.001), which were identified as independent prognostic variables in multivariate analysis (P<0.001). The present study demonstrated that the CRP/Alb ratio and NLR were independent prognostic factors for OS in patients with GC. The combination of these indexes was associated with significant prognostic value and may further stratify prognosis.
Introduction
Gastric cancer (GC) is one of the most common types of tumor globally. In 2015, GC had the second highest incidence and rate of mortality among cancer patients in China (1) . Due to the rapid progression of GC and the absence of early specific symptoms and signs, the majority of patients are diagnosed at the late stage of gastric carcinoma (2) (3) (4) (5) . At present, surgery is the preferred treatment for patients without distant metastasis, and postoperative metastasis and recurrence are the predominant causes of mortality (3, 5) . Although disease-free and overall survival (OS) may be improved by postoperative chemotherapy and radiotherapy, the prognosis of GC remains poor (3, 6) . Identifying simple but effective prognostic markers for GC remains an important aim for researchers.
Inflammation occurs in various types of tumor, and serves a crucial function in tumor development and distant metastasis (7) (8) (9) (10) . Previous studies have indicated that inflammation is associated with the formation of the tumor microenvironment by inflammatory mediators, including vasoactive amines and cytokines (11) (12) (13) . The C-reactive protein (CRP)/albumin (Alb) ratio is used as a novel inflammation-based prognostic indicator in multiple types of tumor. Previous studies have demonstrated the prognostic value of CRP/Alb ratio in colorectal (14) and esophageal cancer (15) , hepatocellular carcinoma (16) , and renal (17) and pancreatic cancer (18) . Another important inflammatory marker is the neutrophil/lymphocyte ratio (NLR). NLR represents the balance between inflammatory activation and regulatory factors (19) . Increased NLR may also serve as an independent prognostic risk factor in multiple types of cancer, including lung (20) and breast cancer (21) , renal cell carcinoma (22) , and ovarian cancer (23 Statistical analysis. Data are expressed as the mean ± standard deviation. The significance of association between the CRP/Alb ratio or NLR, and the clinicopathological characteristics were assessed using the χ 2 test. OS was defined as the time interval between diagnosis and mortality due to GC or the last follow-up. The optimal cut-off points for continuous prognostic indices were determined using the method reported by Budczies et al (25) . Survival curves were constructed using the Kaplan-Meier method. Differences in survival were assessed using the log-rank test. The Cox proportional hazards regression model was used for univariate and multivariate analysis. The significant prognostic factors identified in univariate analysis were selected for multivariate analysis. All statistical analyses were performed using SPSS 13.0 (SPSS, Inc., Chicago, IL, USA). A two-tailed P<0.05 was considered to indicate a statistically significant difference.
Results

Patient characteristics.
A total of 337 patients were included for analysis in the present study; however, some of the patients' data of tumor size, location and differentiation level were lost. Of the available data, 42 (12.5%), 49 Association between CRP/Alb ratio, NLR and clinicopathological characteristics. The association between CRP/Alb ratio and NLR, and clinicopathological characteristics was assessed (Table I ). The CRP/Alb ratio ranged from 0.003-4.77 (median, 0.23), and NLR ranged from 0.47-23.00 (median, 2.95). For OS, the optimal cut-off values of the CRP/Alb ratio and NLR were 0.38 and 3.41, respectively. The present study revealed that high CRP/Alb ratio and NLR values were associated with increased tumor invasion (CRP/Alb, P=0.006; NLR, P= 0.005), increased distant metastasis (CRP/Alb, P<0.001; NLR, P<0.001) and a more advanced TNM stage (CRP/Alb, P<0.001; NLR, P<0.001). In addition, a high NLR value was associated with increased tumor size (P=0.02).
Prognostic value of the CRP/Alb ratio, NLR and OS.
The median survival time for the patients was 29.77 months (range, 0.43-59.57 months). Survival analysis revealed that patients with a high CRP/Alb ratio were associated with a significantly decreased OS rate compared with those with a decreased CRP/Alb ratio (P<0.001; Fig. 1 ). Similarly, patients with a high NLR value were associated with a significantly decreased OS rate compared with those with a low NLR (P<0.001; Fig. 2 ). In univariate analysis, age (P=0.005), tumor location (P<0.001), TNM stage (P<0.001), distant metastasis (P<0.001), surgery (P<0.001), CRP/Alb ratio (P<0.001) and NLR (P<0.001) were revealed to be significantly associated with OS. Multivariate analysis identified age (P<0.001), TNM stage (P<0.001), surgery (P= 0.002), CRP/Alb ratio (P= 0.005) and NLR (P=0.001) as independent prognostic factors (Table II) .
Prognostic value of the CRP/Alb ratio and NL R classification.
According to the optimal cut-off values of the CRP/Alb ratio (<0.38/≥0.38) and NLR (<3.41/≥3.41), the present study classified the patients into subgroups: Group I, patients with increased CRP/Alb ratio (≥0.38) and NLR (≥3.14); group III, patients with decreased CRP/Alb ratio (<0.38) and NLR (<3.14); and group II, all remaining patients. Among the 337 patients, 29 (8.60%) patients were located in group I, 76 (22.55%) patients were located in group II and 232 (68.84%) patients were located in group III. Fig. 3 ; Table III ). Univariate analysis revealed that age (P= 0.005), tumor location (P<0.001), TNM stage (P<0.001), distant metastasis (P<0.001), surgery (P<0.001), and CRP/Alb ratio and NLR classification (P<0.001) were significant prognostic factors. Multivariate analysis also demonstrated that these parameters, with the exception of tumor location, were significant prognostic factors. Notably, the CRP/Alb ratio and NLR classification (P<0.001) was identified as an independent prognostic factor in univariate and multivariate analyses (Table III) .
Discussion
GC is a common malignant tumor of the upper digestive tract. In 2015, GC exhibited the second highest incidence and mortality rate among various types of cancer in China (1) . In previous studies, plasma fibrinogen (26), α-fetoprotein (27) , carcinoembryonic antigen-related cell adhesion molecule 5 (28) and the platelet/lymphocyte ratio (29) were demonstrated to be prognostic indicators for GC with the same TNM stage. The levels of CRP, Alb, neutrophils and lymphocytes are all routinely tested in clinical practice, which means that data on these parameters are readily available. The present study revealed that CRP/Alb ratio and NLR served as independent prognostic factors for OS in patients with GC. The combination of these indexes was associated with significant prognostic value and may further stratify prognosis.
The association between inflammation and cancer is complex. During the inflammatory response, cytokines [e.g., interleukin (IL)-6] and chemokines (e.g., C-C motif chemokine ligand 2 and C-X-C motif chemokine ligand 8) are produced, which may activate signal transducer and activator Table I . Association between the CRP/ALB ratio and NLR with clinicopathological characteristics in patients with gastric cancer. of transcription 3 and nuclear factor κB, and recruit an increased number of inflammatory cells, including neutrophilic granulocytes and mononuclear macrophages, to the lesion site and thereby assist in forming an inflammatory microenvironment (13, 30, 31) . The interaction between tumor cells and inflammatory factors may suppress the immunosurveillance of T and natural killer cells (32) , enhance the permeability of blood and lymphatic vessels and degrade the extracellular matrix, thereby potentiating tumor development and metastasis (12, 33) . Furthermore, tumor cells may secrete inflammatory mediators and thereby assist in forming an inflammatory microenvironment (34) .
CRP and Alb are produced by liver cells. CRP is an acute phase protein regulated by IL-6, tumor necrosis factor and other inflammatory factors (35) . Therefore, CRP may indicate inflammation. Previous studies have demonstrated that an increased level of CRP may be associated with poorer prognosis in patients with tumors, including ovarian cancer, penile cancer and non-small cell lung cancer (36) (37) (38) . In addition, malabsorption and malnutrition may be associated with decreased survival time in various tumors, including esophageal squamous cell carcinomas and endometrial cancer (39, 40) . In a previous study, Alb was used to estimate nutritional status. For patients with GC, protein digestion and absorption were decreased, whereas protein metabolism was increased, resulting in a negative nitrogen balance (18, 39) . The CRP/Alb ratio is a useful prognostic indicator that was initially used to identify patients with serious conditions on an acute medical ward by Fairclough et al (41) . Subsequently, multiple studies have demonstrated that the CRP/Alb ratio exhibited prognostic value in numerous types of cancer (15) (16) (17) (18) 42) . The present study revealed that a high CRP/Alb ratio indicated increased tumor invasion and metastasis and poorer prognosis compared with a low CRP/Alb ratio.
NLR serves as an index in routine blood tests. Multiple studies have confirmed that NLR is an easily available and reliable marker, which is associated with poor prognosis in various malignancies (19) (20) (21) (22) (23) . The present study revealed that NLR was significantly associated with TNM stage, tumor invasion, tumor size, distant metastasis and poor prognosis, which was consistent with a previous study (43) . The balance between the inflammatory and immune response is also reflected by NLR. Neutrophils contribute to inflammation by activating pro-angiogenic factors, including vascular endothelial growth factor or inflammatory cytokines (e.g., IL-1β) (44, 45) . In addition, these neutrophils may also secrete agents that promote tumor cellular proliferation, angiogenesis, invasion and metastasis (46) , and they may inhibit T cells (47) . As important components of the non-specific and adaptive immune response, lymphocytes are able to destroy tumor cells via cytotoxic cells and cytokine secretion (48) . A decreased lymphocyte count results in reduced tumor resistance (49) . These mechanisms support the results of the present study.
The multivariate analysis of the present study demonstrated that the CRP/Alb ratio and NLR exhibited significant prognostic value in GC. In the present study, the patients were classified according to CRP/Alb ratio (<0.38/≥0.38) and NLR (<3. 41/v3.41) . In groups I, II, and III, the median OS was 5.10, 17.80 and 46.50 months, respectively. The survival difference among the subgroups may be due to the CRP/Alb ratio and NLR, which reflect a combination of inflammation, immune and nutrition status caused by tumor progression Therefore, the combination of the CRP/Alb ratio and NLR was associated with significant prognostic value in GC.
Although the prognostic value of the CRP/Alb ratio and NLR in GC has been reported previously (42, 50) , to the best of our knowledge, the present study is the first to report that the that the combination of the CRP/Alb ratio and NLR is associated with significant prognostic value and may further stratify prognosis compared with using single indicators.
However, the present study has a number of limitations. The present study was a retrospective analysis, and the Table II . Prognostic value of the CRP/ALB ratio and NLR for overall survival in patients with gastric cancer by univariate and multivariate analysis.
Univariate analysis
Multivariate analysis AJCC. The cut-off points for age, the CRP/ALB ratio, and NLR were determined using the method reported by Budczies et al (25) . TNM, tumor-node-metastasis; AJCC, American Joint Committee on Cancer; CI, confidence interval; CRP, C-reactive protein; ALB, albumin; NLR, neutrophil/lymphocyte ratio. conclusions require confirmation by perspective studies. Secondly, the present study did not use a uniform cut-off value for the CRP/Alb ratio and NLR. Therefore, different statistical methods may obtain different thresholds. However, the method used by the present study was based on R, which has been reliably used by other studies (15, 51, 52) . To conclude, the present study revealed that the combination of the CRP/Alb ratio and NLR represents a potential inflammation-based prognostic marker. This marker was associated with invasive clinicopathological characteristics and was able to predict prognosis in patients with GC. Larger, prospective studies are required to evaluate the results of the present study in the context of other types of malignancy. Table III . Prognostic value of the CRP/ALB ratio and NLR for overall survival in patients with gastric cancer by univariate and multivariate analysis. Statistically significant prognostic factor identified using univariate or multivariate analysis. b AJCC. Group I, patients with increased CRP/ALB ratio (>0.3778) and NLR (>3.14); group III, patients with decreased CRP/ALB ratio (≤0.3778) and NLR (≤3.14); group II, all remaining patients. CRP, C-reactive protein; ALB, albumin; NLR, neutrophil/lymphocyte ratio; TNM, tumor-node-metastasis; AJCC, American Joint Committee on Cancer.
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